Skip to content

Effects of Remimazolam, Propofol, and Sevoflurane on Emergence Agitation in Patients Undergoing Oral Surgery: A Multicenter, Randomized, Controlled Trial

Effects of Remimazolam, Propofol, and Sevoflurane on Emergence Agitation in Patients Undergoing Oral Surgery: A Multicenter, Randomized, Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114045
Enrollment
Unknown
Registered
2025-12-05
Start date
2025-12-15
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence agitation (EA) is a common complication following general anesthesia, characterized by a state of confusion, disorientation, restlessness, crying, or purposeless movements during the recovery period.

Interventions

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 70 years; 2.ASA physical status I to III; 3.Scheduled for elective oral surgery under general anesthesia with nasotracheal intubation;

Exclusion criteria

Exclusion criteria: 1.Body mass index (BMI) >35 kg/m^²; 2.General anesthesia or sedation within one month prior to surgery; 3.Ischemic heart disease, NYHA >= class III, acute coronary syndrome or stroke within 3 months; 4.Pre-existing neuropsychiatric disorders (e.g., history of schizophrenia, epilepsy, Parkinson's disease, or Alzheimer's disease); 5.Hepatic dysfunction (Child-Pugh C); 6.Renal insufficiency (eGFR 11 mmol/L); 8.Skull base fracture; 9.Previous nasal surgery, severe deviated nasal septum, or recurrent epistaxis;

Design outcomes

Primary

MeasureTime frame
The incidence of emergence agitation;

Secondary

MeasureTime frame
Quality of recovery at 24 hours postoperatively;

Countries

China

Contacts

Public ContactKePeng

The First Affiliated Hospital of Soochow University

pengke0422@163.com+86 512 6778 0156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026